FDA Grand Rounds – Clinical Omics Biomarker Discovery and Validation in Precision Medicine Applications Thursday, April 9, 2026 12:00 p.m. - 1:00 p.m. ET

https://www.fda.gov/science-research/about-science-research-fda/fda-grand-rounds?utm_medium=email&utm_source=govdelivery Date: Thursday, April 9, 2026 Time: 12:00 pm - 1:00 pm ET Via webcast About the Presentation: This lecture will provide an overview of Systems Biology omics and biomarker concepts with four examples of omics analyses of human blood samples. The examples include metabolomics and miRNA analysis of serum during acetaminophen-induced liver toxicity, proteomic analysis of serum to predict kidney recovery from dialysis, baseline proteomics analysis of blood from patients receiving doxorubicin treatment, and method for discovery and validation of miRNA-proteins pairs in plasma associated with respiratory disease.